vs

Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $32.6M, roughly 1.8× RxSight, Inc.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -28.1%, a 15.5% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs -18.9%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -0.0%).

CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CBAT vs RXST — Head-to-Head

Bigger by revenue
CBAT
CBAT
1.8× larger
CBAT
$58.8M
$32.6M
RXST
Growing faster (revenue YoY)
CBAT
CBAT
+150.7% gap
CBAT
131.8%
-18.9%
RXST
Higher net margin
CBAT
CBAT
15.5% more per $
CBAT
-12.5%
-28.1%
RXST
More free cash flow
CBAT
CBAT
$18.3M more FCF
CBAT
$16.1M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-0.0%
CBAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBAT
CBAT
RXST
RXST
Revenue
$58.8M
$32.6M
Net Profit
$-7.4M
$-9.2M
Gross Margin
7.3%
77.5%
Operating Margin
-13.6%
-34.8%
Net Margin
-12.5%
-28.1%
Revenue YoY
131.8%
-18.9%
Net Profit YoY
-63.6%
-54.1%
EPS (diluted)
$-0.08
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAT
CBAT
RXST
RXST
Q4 25
$58.8M
$32.6M
Q3 25
$60.9M
$30.3M
Q2 25
$40.5M
$33.6M
Q1 25
$34.9M
$37.9M
Q4 24
$25.4M
$40.2M
Q3 24
$44.6M
$35.3M
Q2 24
$47.8M
$34.9M
Q1 24
$58.8M
$29.5M
Net Profit
CBAT
CBAT
RXST
RXST
Q4 25
$-7.4M
$-9.2M
Q3 25
$2.7M
$-9.8M
Q2 25
$-3.1M
$-11.8M
Q1 25
$-1.6M
$-8.2M
Q4 24
$-4.5M
$-5.9M
Q3 24
$17.6K
$-6.3M
Q2 24
$6.4M
$-6.1M
Q1 24
$9.8M
$-9.1M
Gross Margin
CBAT
CBAT
RXST
RXST
Q4 25
7.3%
77.5%
Q3 25
8.0%
79.9%
Q2 25
11.0%
74.9%
Q1 25
13.7%
74.8%
Q4 24
13.1%
71.6%
Q3 24
15.6%
71.4%
Q2 24
26.6%
69.5%
Q1 24
31.9%
70.1%
Operating Margin
CBAT
CBAT
RXST
RXST
Q4 25
-13.6%
-34.8%
Q3 25
-6.6%
-40.1%
Q2 25
-8.7%
-41.6%
Q1 25
-8.2%
-28.2%
Q4 24
-26.0%
-21.5%
Q3 24
-1.9%
-26.1%
Q2 24
12.4%
-23.9%
Q1 24
17.4%
-36.2%
Net Margin
CBAT
CBAT
RXST
RXST
Q4 25
-12.5%
-28.1%
Q3 25
4.4%
-32.4%
Q2 25
-7.6%
-35.0%
Q1 25
-4.5%
-21.6%
Q4 24
-17.8%
-14.8%
Q3 24
0.0%
-17.9%
Q2 24
13.5%
-17.4%
Q1 24
16.7%
-30.8%
EPS (diluted)
CBAT
CBAT
RXST
RXST
Q4 25
$-0.08
$-0.22
Q3 25
$0.03
$-0.24
Q2 25
$-0.03
$-0.29
Q1 25
$-0.02
$-0.20
Q4 24
$-0.05
$-0.14
Q3 24
$0.00
$-0.16
Q2 24
$0.07
$-0.16
Q1 24
$0.11
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAT
CBAT
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$8.3M
$228.1M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$112.7M
$275.7M
Total Assets
$426.2M
$311.8M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAT
CBAT
RXST
RXST
Q4 25
$8.3M
$228.1M
Q3 25
$10.5M
$227.5M
Q2 25
$45.7M
$227.5M
Q1 25
$9.6M
$229.3M
Q4 24
$11.0M
$237.2M
Q3 24
$24.2M
$237.1M
Q2 24
$44.1M
$233.3M
Q1 24
$23.8M
$125.4M
Total Debt
CBAT
CBAT
RXST
RXST
Q4 25
$4.1M
Q3 25
$4.8M
Q2 25
$4.9M
Q1 25
$4.1M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CBAT
CBAT
RXST
RXST
Q4 25
$112.7M
$275.7M
Q3 25
$121.4M
$276.0M
Q2 25
$118.2M
$278.0M
Q1 25
$120.8M
$279.3M
Q4 24
$121.7M
$281.2M
Q3 24
$131.2M
$277.3M
Q2 24
$126.6M
$275.2M
Q1 24
$120.9M
$163.9M
Total Assets
CBAT
CBAT
RXST
RXST
Q4 25
$426.2M
$311.8M
Q3 25
$363.9M
$308.5M
Q2 25
$333.1M
$309.0M
Q1 25
$311.5M
$313.0M
Q4 24
$302.2M
$318.6M
Q3 24
$293.5M
$310.5M
Q2 24
$279.6M
$305.5M
Q1 24
$286.5M
$183.2M
Debt / Equity
CBAT
CBAT
RXST
RXST
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.03×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAT
CBAT
RXST
RXST
Operating Cash FlowLast quarter
$29.8M
$-1.1M
Free Cash FlowOCF − Capex
$16.1M
$-2.3M
FCF MarginFCF / Revenue
27.3%
-6.9%
Capex IntensityCapex / Revenue
23.4%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAT
CBAT
RXST
RXST
Q4 25
$29.8M
$-1.1M
Q3 25
$14.6M
$-1.2M
Q2 25
$13.8M
$-4.4M
Q1 25
$-9.6M
$-8.8M
Q4 24
$9.6M
$-4.3M
Q3 24
$19.7M
$650.0K
Q2 24
$2.9M
$-4.0M
Q1 24
$7.4M
$-9.3M
Free Cash Flow
CBAT
CBAT
RXST
RXST
Q4 25
$16.1M
$-2.3M
Q3 25
$6.0M
$-1.8M
Q2 25
$4.1M
$-5.9M
Q1 25
$-22.3M
$-9.4M
Q4 24
$3.9M
$-5.1M
Q3 24
$16.5M
$-453.0K
Q2 24
$2.5M
$-5.5M
Q1 24
$-454.0K
$-11.3M
FCF Margin
CBAT
CBAT
RXST
RXST
Q4 25
27.3%
-6.9%
Q3 25
9.9%
-5.8%
Q2 25
10.2%
-17.6%
Q1 25
-63.9%
-24.8%
Q4 24
15.5%
-12.7%
Q3 24
37.1%
-1.3%
Q2 24
5.2%
-15.9%
Q1 24
-0.8%
-38.2%
Capex Intensity
CBAT
CBAT
RXST
RXST
Q4 25
23.4%
3.5%
Q3 25
14.1%
1.9%
Q2 25
23.8%
4.6%
Q1 25
36.3%
1.5%
Q4 24
22.5%
2.1%
Q3 24
7.0%
3.1%
Q2 24
0.9%
4.4%
Q1 24
13.4%
6.7%
Cash Conversion
CBAT
CBAT
RXST
RXST
Q4 25
Q3 25
5.51×
Q2 25
Q1 25
Q4 24
Q3 24
1115.72×
Q2 24
0.46×
Q1 24
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAT
CBAT

Manufacturing Lithium Batteries$28.0M48%
Residential Energy Supply And Uninterruptable Supplies$17.8M30%
Light Electric Vehicles$12.9M22%
Precursor$108.0K0%

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons